GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Avarept® | compound 1 [WO2024071349] | SJP-0132 | SJP0132
motugivatrep is an approved drug
Compound class:
Synthetic organic
Comment: Motugivatrep (SJP-0132) is a selective transient receptor potential cation channel subfamily V member 1 (TRPV1) antagonist [3]. It was designed to ameliorate the signs and symptoms dry eye disease.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. Japan PMDA (2025) |
IUPAC Name ![]() |
| (2E)-N-[(7R)-7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]-2-[7-(trifluoromethyl)-2,3-dihydrochromen-4-ylidene]acetamide |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 12048 | motugivatrep |
Synonyms ![]() |
| Avarept® | compound 1 [WO2024071349] | SJP-0132 | SJP0132 |
Database Links ![]() |
|
| CAS Registry No. | 920332-28-1 (source: WHO INN record) |
| ChEMBL Ligand | CHEMBL5095073 |
| DrugBank Ligand | DB21546 |
| PubChem CID | 137350798 |
| Search Google for chemical match using the InChIKey | MAWBBYZCTDJMDD-HFQYIWAZSA-N |
| Search Google for chemicals with the same backbone | MAWBBYZCTDJMDD |
| Search PubMed clinical trials | motugivatrep |
| Search PubMed titles | motugivatrep |
| Search PubMed titles/abstracts | motugivatrep |
| UniChem Compound Search for chemical match using the InChIKey | MAWBBYZCTDJMDD-HFQYIWAZSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | MAWBBYZCTDJMDD-HFQYIWAZSA-N |